摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-chloro-2-methoxyphenylmagnesium bromide, 0.50 m in thf | 1213256-49-5

中文名称
——
中文别名
——
英文名称
4-chloro-2-methoxyphenylmagnesium bromide, 0.50 m in thf
英文别名
——
4-chloro-2-methoxyphenylmagnesium bromide, 0.50 m in thf化学式
CAS
1213256-49-5
化学式
C7H6BrClMgO
mdl
——
分子量
245.786
InChiKey
GSPRMVLXEQJHIL-UHFFFAOYSA-M
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.99
  • 重原子数:
    11.0
  • 可旋转键数:
    2.0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    9.23
  • 氢给体数:
    0.0
  • 氢受体数:
    1.0

SDS

SDS:adb46d359e802cbda30f42c6635b45b4
查看

反应信息

  • 作为反应物:
    描述:
    4-chloro-2-methoxyphenylmagnesium bromide, 0.50 m in thf 在 bis(norbornadiene)rhodium(l)tetrafluoroborate 、 (R,R)-1-[1-(di(t-butyl)phosphino)ethyl]-2-(diphenylphosphino)ferrocene 、 氢气 、 zinc trifluoromethanesulfonate 、 lithium hexamethyldisilazane 作用下, 以 四氢呋喃2-甲基四氢呋喃甲苯 为溶剂, 50.0 ℃ 、300.01 kPa 条件下, 反应 37.0h, 生成 (S)-2-(4-chloro-2-methoxyphenyl)-2-((3-methoxy-5-(methylsulfonyl)phenyl)amino)-1-(5-(trifluoromethoxy)-1H-indol-3-yl)ethanone
    参考文献:
    名称:
    [EN] PROCESSES FOR THE PREPARATION OF (S)-2-(4-CHLORO-2-METHOXYPHENYL)-2-((3-METHOXY-5-(METHYLSULFONYL)PHENYL)AMINO)-1 -(1H-INDOL-3-YL)ETHENONE DERIVATIVES
    [FR] PROCÉDÉS POUR LA PRÉPARATION DE DÉRIVÉS DE (S)-2-(4-CHLORO-2-MÉTHOXYPHÉNYL)-2-((3-MÉTHOXY-5-(MÉTHYLSULFONYL)PHÉNYL)AMINO)-1 -(1H-INDOL-3-YL)ÉTHÉNONE
    摘要:
    The present invention relates to a chiral synthesis of mono- or di-substituted (S)-2-(4-chloro-2-methoxyphenyl)-2-((3-methoxy-5-(methylsulfonyl)phenyl)amino)-1-(1H-indol-3-yl)ethenone derivatives of formula (I) by a) reacting a 1-(4-chloro-2-methoxyphenyl)-2-(1H-indol-3-yl)ethane-1, 2-dione derivative of formula (II) with 3-methoxy-5-(methylsulfonyl)aniline to produce a 2-(4-chloro-2-methoxyphenyl)-2-((3-methoxy-5-(methylsulfonyl) phenyl)imino)-1-(1H-indol-3-yl)ethanone derivative of formula (II), and b) hydrogenation of this compound of formula (II) to produce the title compound of formula (I).
    公开号:
    WO2023274237A1
  • 作为产物:
    参考文献:
    名称:
    [EN] PROCESSES FOR THE PREPARATION OF (S)-2-(4-CHLORO-2-METHOXYPHENYL)-2-((3-METHOXY-5-(METHYLSULFONYL)PHENYL)AMINO)-1 -(1H-INDOL-3-YL)ETHENONE DERIVATIVES
    [FR] PROCÉDÉS POUR LA PRÉPARATION DE DÉRIVÉS DE (S)-2-(4-CHLORO-2-MÉTHOXYPHÉNYL)-2-((3-MÉTHOXY-5-(MÉTHYLSULFONYL)PHÉNYL)AMINO)-1 -(1H-INDOL-3-YL)ÉTHÉNONE
    摘要:
    The present invention relates to a chiral synthesis of mono- or di-substituted (S)-2-(4-chloro-2-methoxyphenyl)-2-((3-methoxy-5-(methylsulfonyl)phenyl)amino)-1-(1H-indol-3-yl)ethenone derivatives of formula (I) by a) reacting a 1-(4-chloro-2-methoxyphenyl)-2-(1H-indol-3-yl)ethane-1, 2-dione derivative of formula (II) with 3-methoxy-5-(methylsulfonyl)aniline to produce a 2-(4-chloro-2-methoxyphenyl)-2-((3-methoxy-5-(methylsulfonyl) phenyl)imino)-1-(1H-indol-3-yl)ethanone derivative of formula (II), and b) hydrogenation of this compound of formula (II) to produce the title compound of formula (I).
    公开号:
    WO2023274237A1
点击查看最新优质反应信息

文献信息

  • [EN] MCL-1 MODULATING COMPOSITIONS<br/>[FR] COMPOSITIONS DE MODULATION DE MCL-1
    申请人:PENN STATE RES FOUND
    公开号:WO2013112878A1
    公开(公告)日:2013-08-01
    The present invention relates to marinopyrrole A derivatives and pyoluteorin derivatives and methods of treatment of disorders associated with misregulation of Mcl-l, e.g., leukemia, lymphoma, multiple myeloma, melanoma, or pancreatic cancer. We describe exemplary compounds, which may be contained in pharmaceutical compositions, and their use as therapeutic agents either alone or in combination with other anti-cancer treatments, e.g., anti-Bcl- 2 agents.
    本发明涉及海洋吡咯酮A衍生物洛特霉素衍生物,以及治疗与Mcl-l误调节相关的疾病的方法,例如白血病、淋巴瘤、多发性骨髓瘤、黑色素瘤或胰腺癌。我们描述了一些示范性化合物,这些化合物可以包含在药物组合物中,并且它们可作为治疗剂单独使用或与其他抗癌治疗方法结合使用,例如抗Bcl-2剂。
  • Compounds for inhibiting NLRP3 and uses thereof
    申请人:Ventus Therapeutics U.S., Inc.
    公开号:US11319319B1
    公开(公告)日:2022-05-03
    The present disclosure relates to inhibitors of NLRP3 useful in the treatment of diseases and disorders inhibited by said protein and having the Formula (I):
    本公开涉及NLRP3抑制剂,用于治疗被该蛋白抑制的疾病和障碍,并具有公式(I):
  • Electronic Influences in Phosphinesulfonato Palladium(II) Polymerization Catalysts
    作者:Philipp Wucher、Verena Goldbach、Stefan Mecking
    DOI:10.1021/om400297x
    日期:2013.8.26
    To study the influence of electronics on catalytic polymerization properties independent from sterics, phosphinesulfonato Pd(II) complexes bearing remotely located substituents on the nonchelating P-bound aryls [kappa(2)-(P,O)-(4-R-2-anisyl)(2)PC6H4SO2O]Pd(Me)(dmso) (1ae-dmso: 1a, R = CF3; 1b, R = Cl; 1c, R = H; 1d, R = CH3; 1e, R = OCH3) were prepared. The electron-poor complex 1a-dmso (4-CF3) undergoes the fastest insertion of methyl acrylate (MA) and is the most active for ethylene polymerization. The polyethylene molecular weight increases by a factor of 2 for the more electron rich complex 1e-dmso (4-OCH3) (Mn = 17 x 10 (3) vs 8 x 10 (3) for 1a-dmso (4-CF3)). MA/ethylene copolymerization experiments revealed that the MA incorporation ratio and copolymer molecular weights are largely independent of the electronic nature of the remote substituents. These trends were further confirmed by studies of two mixed P-aryl/-alkyl complexes 1f-dmso ([kappa(2)-(2,4,6-(OMe)(3)C6H2)(tBu)PC6H4SO2O]Pd(Me)(dmso)) and 1g-dmso ([?2-(C6H5)(tBu)PC6H4SO2O]Pd(Me)(dmso)). In ethylene/MA copolymerization, 1f-dmso affords a significantly higher molecular weight polymer with reasonable MA incorporation (Mn = 12 x 10 (3) and 7.7 mol % MA) and activities similar to those observed for complexes 1ae-dmso.
  • WO2024097629A1
    申请人:——
    公开号:——
    公开(公告)日:——
  • US11618751
    申请人:——
    公开号:——
    公开(公告)日:——
查看更多

同类化合物

(R)-3-(叔丁基)-4-(2,6-二异丙氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (2S,3R)-3-(叔丁基)-2-(二叔丁基膦基)-4-甲氧基-2,3-二氢苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2R,2''R,3R,3''R)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2-氟-3-异丙氧基苯基)三氟硼酸钾 (+)-6,6'-{[(1R,3R)-1,3-二甲基-1,3基]双(氧)}双[4,8-双(叔丁基)-2,10-二甲氧基-丙二醇 麦角甾烷-6-酮,2,3,22,23-四羟基-,(2a,3a,5a,22S,23S)- 鲁前列醇 顺式6-(对甲氧基苯基)-5-己烯酸 顺式-铂戊脒碘化物 顺式-四氢-2-苯氧基-N,N,N-三甲基-2H-吡喃-3-铵碘化物 顺式-4-甲氧基苯基1-丙烯基醚 顺式-2,4,5-三甲氧基-1-丙烯基苯 顺式-1,3-二甲基-4-苯基-2-氮杂环丁酮 非那西丁杂质7 非那西丁杂质3 非那西丁杂质22 非那西丁杂质18 非那卡因 非布司他杂质37 非布司他杂质30 非布丙醇 雷诺嗪 阿达洛尔 阿达洛尔 阿莫噁酮 阿莫兰特 阿维西利 阿索卡诺 阿米维林 阿立酮 阿曲汀中间体3 阿普洛尔 阿普斯特杂质67 阿普斯特中间体 阿普斯特中间体 阿托西汀EP杂质A 阿托莫西汀杂质24 阿托莫西汀杂质10 阿托莫西汀EP杂质C 阿尼扎芬 阿利克仑中间体3 间苯胺氢氟乙酰氯 间苯二酚二缩水甘油醚 间苯二酚二异丙醇醚 间苯二酚二(2-羟乙基)醚 间苄氧基苯乙醇 间甲苯氧基乙酸肼 间甲苯氧基乙腈 间甲苯异氰酸酯